{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:48:53Z","timestamp":1783158533518,"version":"3.54.6"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,20]]},"DOI":"10.7759\/cureus.18116","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T12:06:20Z","timestamp":1632139580000},"source":"Crossref","is-referenced-by-count":6,"title":["Tranexamic Acid for the Emergency Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema"],"prefix":"10.7759","author":[{"given":"Shannon","family":"Hasara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Amatea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2013.34.3640","article-title":"National estimates of emergency department visits for angioedema and allergic reactions in the United States","volume":"34","author":"Kelly M","year":"2013","unstructured":"Kelly M, Donnelly JP, McAnnally JR, Wang HE. National estimates of emergency department visits for angioedema and allergic reactions in the United States. Allergy Asthma Proc. 2013, 34:150-4. 10.2500\/aap.2013.34.3640","journal-title":"Allergy Asthma Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2019.5.42650","article-title":"Evaluation and management of angioedema in the emergency department","volume":"20","author":"Long BJ","year":"2019","unstructured":"Long BJ, Koyfman A, Gottlieb M. Evaluation and management of angioedema in the emergency department. West J Emerg Med. 2019, 20:587-600. 10.5811\/westjem.2019.5.42650","journal-title":"West J Emerg Med"},{"key":"ref3","unstructured":"NCHS data brief. Prescription drug use among adults aged 40-79 in the United States and Canada. (2019). Accessed: May 7, 2021: https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db347.htm."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106081","article-title":"ACE inhibitor-mediated angioedema","volume":"78","author":"Montinaro V","year":"2020","unstructured":"Montinaro V, Cicardi M. ACE inhibitor-mediated angioedema. Int Immunopharmacol. 2020, 78:106081. 10.1016\/j.intimp.2019.106081","journal-title":"Int Immunopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2013.34.3664","article-title":"Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema","volume":"34","author":"Gang C","year":"2013","unstructured":"Gang C, Lindsell CJ, Moellman J, Sublett W, Hart K, Collins S, Bernstein JA. Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema. Allergy Asthma Proc. 2013, 34:267-73. 10.2500\/aap.2013.34.3664","journal-title":"Allergy Asthma Proc"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12341","article-title":"A consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman JJ","year":"2014","unstructured":"Moellman JJ, Bernstein JA, Lindsell C, et al.. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014, 21:469-84. 10.1111\/acem.12341","journal-title":"Acad Emerg Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.12.115","article-title":"Time frame of recurrent angioedema following discontinuation of angiotensin converting enzyme inhibitor medications","volume":"141","author":"Kallepalli A","year":"2018","unstructured":"Kallepalli A, Yusin JS. Time frame of recurrent angioedema following discontinuation of angiotensin converting enzyme inhibitor medications. J Allergy Clin Immunol. 2018, 141:35. 10.1016\/j.jaci.2017.12.115","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.051","article-title":"Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema","volume":"140","author":"Straka BT","year":"2017","unstructured":"Straka BT, Ramirez CE, Byrd JB, et al.. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema. J Allergy Clin Immunol. 2017, 140:242-8. 10.1016\/j.jaci.2016.09.051","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2014.12.007","article-title":"Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department","volume":"114","author":"Bernstein JA","year":"2015","unstructured":"Bernstein JA, Moellman JJ, Collins SP, Hart KW, Lindsell CJ. Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department. Ann Allergy Asthma Immunol. 2015, 114:245-9. 10.1016\/j.anai.2014.12.007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2014.07.014","article-title":"Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial","volume":"65","author":"Lewis LM","year":"2015","unstructured":"Lewis LM, Graffeo C, Crosley P, et al.. Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial. Ann Emerg Med. 2015, 65:204-13. 10.1016\/j.annemergmed.2014.07.014","journal-title":"Ann Emerg Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.03.003","article-title":"Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema","volume":"5","author":"Sinert R","year":"2017","unstructured":"Sinert R, Levy P, Bernstein JA, et al.. Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema. J Allergy Clin Immunol Pract. 2017, 5:1402-9. 10.1016\/j.jaip.2017.03.003","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2500\/ar.2016.7.0166","article-title":"Angiotensin-converting enzyme inhibitor-associated angioedema treated with c1-esterase inhibitor: a case report and review of the literature","volume":"7","author":"Erickson DL","year":"2016","unstructured":"Erickson DL, Coop CA. Angiotensin-converting enzyme inhibitor-associated angioedema treated with c1-esterase inhibitor: a case report and review of the literature. Allergy Rhinol (Providence). 2016, 7:168-71. 10.2500\/ar.2016.7.0166","journal-title":"Allergy Rhinol (Providence)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12245-017-0141-z","article-title":"Angioedema in the emergency department: a practical guide to differential diagnosis and management","volume":"10","author":"Bernstein JA","year":"2017","unstructured":"Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. 2017, 10:15. 10.1186\/s12245-017-0141-z","journal-title":"Int J Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2018.04.014","article-title":"Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors. (Article in French)","volume":"39","author":"Beauch\u00eane C","year":"2018","unstructured":"Beauch\u00eane C, Martins-H\u00e9richer J, Denis D, Martin L, Maillard H. Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors. (Article in French). Rev Med Interne. 2018, 39:772-6. 10.1016\/j.revmed.2018.04.014","journal-title":"Rev Med Interne"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.10.029","article-title":"Tranexamic acid for ACE inhibitor induced angioedema","volume":"43","author":"Wang K","year":"2021","unstructured":"Wang K, Geiger H, McMahon A. Tranexamic acid for ACE inhibitor induced angioedema. Am J Emerg Med. 2021, 43:292.e5-7. 10.1016\/j.ajem.2020.10.029","journal-title":"Am J Emerg Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2019.12.058","article-title":"Emergency department evaluation of patients with angiotensin converting enzyme inhibitor associated angioedema","volume":"38","author":"Mudd PA","year":"2020","unstructured":"Mudd PA, Hooker EA, Stolz U, Hart KW, Bernstein JA, Moellman JJ. Emergency department evaluation of patients with angiotensin converting enzyme inhibitor associated angioedema. Am J Emerg Med. 2020, 38:2596-601. 10.1016\/j.ajem.2019.12.058","journal-title":"Am J Emerg Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.29328\/journal.hor.1001020","article-title":"Management of acute tongue swelling","volume":"4","author":"Keh SM","year":"2020","unstructured":"Keh SM, Hasan M, Vallamkondu V, Shakeel M. Management of acute tongue swelling. Heighpubs Otolaryngol Rhinol. 2020, 4:12-17. 10.29328\/journal.hor.1001020","journal-title":"Heighpubs Otolaryngol Rhinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/69723-tranexamic-acid-for-the-emergency-treatment-of-angiotensin-converting-enzyme-inhibitor-induced-angioedema","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:40Z","timestamp":1707506980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/69723-tranexamic-acid-for-the-emergency-treatment-of-angiotensin-converting-enzyme-inhibitor-induced-angioedema"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.18116","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,20]]}}}